Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
JMIR Research Protocols|March 2, 2023
Promoting Self-management and Patient Activation Through eHealth: Protocol for a Systematic Literature Review and Meta-analysisSaeed Moradian, Roma Maguire, Geoffrey Liu, et al.
Nature Communications|September 29, 2025
Interleukin-12 anchored drug conjugate (tolododekin alfa) in patients with advanced solid tumors: first-in-human Phase 1 trialJong Chul Park, Brendan Curti, Marcus Butler, et al.
Plos One|June 11, 2021
Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapyMorven Cunningham, Marco Iafolla, Yada Kanjanapan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2019
Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221Anna V Tinker, Holger W Hirte, Diane Provencher, et al.
European Journal of Radiology|January 14, 2023
Combined autologous blood patch-immediate patient rollover does not reduce the pneumothorax or chest drain rate following CT-guided lung biopsy compared to immediate patient rollover aloneJohn A Duignan, David T Ryan, Brian O'Riordan, et al.
Journal of Neuro-Oncology|August 8, 2023
Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosisPaola A Jablonska, Thiago Muniz, Mauricio Ribeiro, et al.
Diagnostic and Interventional Radiology (Ankara, Turkey)|January 10, 2017
Pulmonary fibrosis: tissue characterization using late-enhanced MRI compared with unenhanced anatomic high-resolution CTLisa P Lavelle, Darragh Brady, Sinead McEvoy, et al.
British Journal of Cancer|September 12, 2018
Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006Omid Hamid, Caroline Robert, Antoni Ribas, et al.
Nature Medicine|July 27, 2023
Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim resultsRaffit Hassan, Marcus Butler, Roisin E O'Cearbhaill, et al.
Clinical and Translational Radiation Oncology|June 14, 2019
Computer-assisted image analysis of the tumor microenvironment on an oral tongue squamous cell carcinoma tissue microarraySangjune Laurence Lee, Michael Cabanero, Martin Hyrcza, et al.
Pageof 4